Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs.
about
Molecular cloning and characterization of a transcription regulator with homology to GC-binding factorPrognostic molecular markers in early breast cancerSoluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical RelevanceCloning and characterization of the promoter region of the rat epidermal growth factor receptor gene and its transcriptional regulation by nerve growth factor in PC12 cells.Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanismsIdentification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteinsChromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells.The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.An enhanced and sensitive autocrine stimulation by transforming growth factor-alpha is acquired in the brain metastatic variant of a human non-small-cell lung cancer cell lineDemonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.Cdc42: an effector and regulator of ErbB1 as a strategic target in breast cancer therapy.Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumorsModulation of epidermal growth factor receptor proto-oncogene transcription by a promoter site sensitive to S1 nucleaseMutations in the polybasic juxtamembrane sequence of both plasma membrane- and endoplasmic reticulum-localized epidermal growth factor receptors confer ligand-independent cell transformation.EGFR signaling and autophagy dependence for growth, survival, and therapy resistance.Dysregulation of growth factor-receptor system in cellular transformation.Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.A strong intronic enhancer element of the EGFR gene is preferentially active in high EGFR expressing breast cancer cells.Role of TGF-beta in EGF-induced transformation of NRK cells is sustaining high-level EGF-signaling.Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3p53 Homologue p63 represses epidermal growth factor receptor expression.Heterogeneity in epidermal growth factor responsiveness and tumor growth of human maxillary cancer cell lines.Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptorExpression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor.Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation
P2860
Q24323630-4140057C-EE89-4BA4-A2C6-56A01612319DQ24794845-F85CD2B5-2231-4409-91B0-9B1D64A7C192Q26750970-9BAD5DD2-BA2D-406A-9C34-407AE2104635Q30843762-F7D595EC-1188-4E96-BFB2-9782534E92AAQ33928879-22965F78-7C03-475F-AB8E-A973A90B5280Q33967590-ECCF9A78-8916-4EB2-A1B5-61B3DC3A5C67Q35017851-D39C3FFD-CCD9-4125-AA93-B20FE4E694F0Q35841701-CAA05B87-3707-4D5F-9F8F-BB4AC634C743Q36141268-94341D67-A4F8-4606-BA48-50DD94A42C07Q36205683-A753FE94-A679-4000-8DB1-A5455A5ED206Q36731417-5B0057A9-64CC-49E9-B6E3-B2FCB57DE130Q36787477-FC864E3F-C679-4D65-853F-6E21B8055801Q36846716-38908268-8968-4C68-929F-7EFFD28ECC06Q37349031-92E60CD3-8403-4C5B-883A-19DE9367E55CQ38171032-A835A203-394D-4EAC-A7A1-95C97CCC3D80Q39606599-3078291B-729C-4D08-907B-EDDAB96F3C44Q40659427-1564FFE0-4EAD-4582-A47A-33BF9F53ED5EQ40828610-B4D7069D-36BF-41D5-B775-B9571AC54E3CQ40903711-52C9798C-8B3A-4E2B-B547-4D1B313EB344Q41107277-BE22061B-1E8E-4090-B01D-EFED44EFE0ADQ42509836-23C190D0-71DC-42E8-97CA-1B96F466F4F0Q42806519-DC4F64D7-7A3E-445B-8004-CC43885287F0Q42847452-16B13D27-B49E-4B5B-9169-18CF1D98300AQ52179746-5240B8FA-3995-499A-9E09-21E70055BA60Q58567008-C7826D84-881C-4B26-868E-DCA1AADAF7B4
P2860
Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Human tumor cell lines with EG ...... sence of aberrant sized mRNAs.
@ast
Human tumor cell lines with EG ...... sence of aberrant sized mRNAs.
@en
type
label
Human tumor cell lines with EG ...... sence of aberrant sized mRNAs.
@ast
Human tumor cell lines with EG ...... sence of aberrant sized mRNAs.
@en
prefLabel
Human tumor cell lines with EG ...... sence of aberrant sized mRNAs.
@ast
Human tumor cell lines with EG ...... sence of aberrant sized mRNAs.
@en
P2093
P2860
P356
P1476
Human tumor cell lines with EG ...... sence of aberrant sized mRNAs.
@en
P2093
P2860
P304
P356
10.1093/NAR/13.23.8477
P407
P577
1985-12-01T00:00:00Z